Indian pharma marketing operates under tightening expectations on two fronts at once: the Uniform Code for Pharmaceutical Marketing Practices governing how teams engage HCPs, and the Digital Personal Data Protection Act governing how they handle the data that engagement generates.
UCPMP: conduct by design
Structured engagement with clear documentation is both more effective and more defensible. The same structure that makes a KOL programme measurable makes it auditable, so build governance in, not under audit pressure.
DPDP: consent and purpose
Field and engagement platforms now collect personal data at scale. Lawful processing means clear consent, defined purpose and the ability to honour data-principal rights, which is an architecture decision, not a policy afterthought.
Treat compliance as a feature
The brands that move fastest are the ones that designed for both codes upfront. Compliance stops being a brake when it is part of the system from day one.
How Ichelon helps
We design doctor and KOL engagement around UCPMP and applicable codes, with data handling aligned to DPDP, and the Pharos commercial suite captures engagement with the structure that makes both defensible.
Ready to apply this thinking?
Start a pilot project and evaluate Ichelon's quality within one delivery cycle.